Results 241 to 250 of about 14,136,893 (299)

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

open access: yesMolecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva   +5 more
wiley   +1 more source

Guild Activities [PDF]

open access: yes, 1951
Catholic Physicians\u27 Guilds
core   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

open access: yesMolecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon   +13 more
wiley   +1 more source

The potential of machine learning in classifying relapse and non-relapse in children with clubfoot based on movement patterns. [PDF]

open access: yesSci Rep
Grin L   +6 more
europepmc   +1 more source

ERFA Activities Survey2 [PDF]

open access: yes, 2019
San Jose State University, Emeritus and Retired Faculty Association
core   +1 more source

Home - About - Disclaimer - Privacy